Form 8-K - Current report:
SEC Accession No. 0001104659-11-030874
Filing Date
2011-05-23
Accepted
2011-05-23 17:09:36
Documents
1
Period of Report
2011-05-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-13025_18k.htm 8-K 26344
  Complete submission text file 0001104659-11-030874.txt   27686
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-131722 | Film No.: 11865753
SIC: 2834 Pharmaceutical Preparations